spacer
home > pmps > spring 2019 > a toxic conversation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Toxic Conversation

A cleanroom is one of the biggest single investments any business is likely to make. There are many great reasons why companies literally cannot afford to get it wrong, so it makes sense to ensure it is kept operational for as long as possible. The fact of the matter is that overspecifying on sterilisation could well be increasing the lifetime cost of cleanrooms through the wholly avoidable degradation of furniture and equipment.

All fixtures and fittings in cleanrooms must facilitate Good Manufacturing Practice, meaning that materials from which they are constructed need to be chemically inert. It should also be tough enough to withstand the regular sterilisation, which is why austenitic stainless steel has always been such a common feature in cleanroom design. Furniture and other equipment built from this material will maintain its structural integrity for decades, not years. However, this is only the case when it is looked after properly, which means matching it to the chosen sterilisation option and also ensuring it is not at risk from detergents and disinfectants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which produces hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for cleanroom users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement